ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000250903.4	SL 0101-1	Sarcoma	0.040363416	Resistant
ENSG00000250903.4	SL 0101-1	Bladder urothelial carcinoma	0.020962541	Sensitive
ENSG00000250903.4	SL 0101-1	Thyroid carcinoma	0.000468721	Sensitive